Navigation Links
Anthera Announces the Phase 2b PEARL-SC Data Has Been Accepted as a Late Breaking Poster Presentation at the ACR/ARHP 2012 Annual Scientific Meeting
Date:11/1/2012

HAYWARD, Calif., Nov. 1, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation and autoimmune disorders, today announced that an abstract of the results from the Phase 2b PEARL-SC clinical study examining the treatment effect of blisibimod in systemic lupus erythematosus patients has been accepted as a late-breaking poster presentation at the 2012 Annual Scientific Meeting of the American College of Rheumatology and the Association of Rheumatology Health Professionals (ACR/ARHP).

"We are pleased to have this opportunity to share the PEARLS-SC responder analyses and sub-population results with the rheumatology community," said Colin Hislop, MD, Anthera's Senior Vice President and Chief Medical Officer. "In PEARL-SC, blisibimod demonstrated a clinically meaningful treatment effect in patients with severe disease who continued to have active lupus despite corticosteroid use. This highlights blisibimod's potential to help patients with more active and severe disease as we move forward with our Phase 3 clinical trials."

The poster entitled, "Blisibimod, an Inhibitor of B Cell Activating Factor, in Patients with Moderate-to-Severe Systemic Lupus Erythematosus," is scheduled to be presented by Dr. Richard Furie on Tuesday, November 13, from 9 am – 11 am Eastern Time (Presentation Number L6).

The abstract is available online through the ACR website at www.rheumatology.org. In accordance with the conference's embargo policy, the poster will be uploaded to the Anthera website only after completion of the session.

About Blisibimod and PEARL-SC
BAFF has been associated with a wide range of B-cell-mediated autoimmune diseases, including systemic lupus erythematosus, vasculitis, IgA nephropathy
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Anthera Announces the Advancement of Blisibimod into Phase 3 Development for Patients with Systemic Lupus Erythematosus (SLE)
2. Anthera Pharmaceuticals Reports 2012 Second Quarter Financial Results And Provides Clinical Progress Update
3. Anthera Pharmaceuticals Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Common Stock
4. Anthera Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Anthera Pharmaceuticals Announces Proposed Public Offering of Common Stock
6. Anthera Pharmaceuticals Provides Additional Data from the Recently Completed PEARL-SC Study of Blisibimod in the Proposed Phase 3 Population
7. Anthera Pharmaceuticals to Present at the 7th Annual JMP Securities Healthcare Conference
8. Anthera Updates Phase 3 Plans Following Results from the Phase 2b PEARL-SC Dose Ranging Study of Blisibimod
9. Anthera Pharmaceuticals Reports 2012 First Quarter Financial Results And Provides Clinical Progress Update
10. Anthera Announces First Quarter 2012 Financial Report and Conference Call
11. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014 Medina Medical announced today that Mr. ... the Board of Directors on August 18, 2014. Mr. ... commercialization experience, including over a decade of direct experience ... a Partner of the medical device incubator The Foundry, ... Foundry start-ups. Mr. Engelson previously served as the Chief ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... 29, 2014 According to ... by Extraction type (SFE, Cold Pressed, Organic Solvent, & ... Pharmaceutical, Food Supplements, Fragrance, & Others) - Global Trends ... and segments the Amaranth Seed Oil Market with ... in terms of value. The Amaranth Seed Oil ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4
... Calif., July 26, 2011 Epitomics, Inc., a ... based on its groundbreaking Rabbit Monoclonal (RabMAb®) technology, ... novel cancer-related antibodies that were developed through a ... Cancer Research. The goal of this partnership is ...
... 26, 2011 Bacterin International Holdings, Inc. ... the development of revolutionary bone graft material and anti-infective coatings ... August 11, at 4:30 p.m. Eastern time to discuss results ... will be issued in a press release after the close ...
Cached Medicine Technology:Epitomics Releases New Antibodies Developed With the National Cancer Institute's Center for Cancer Research 2Bacterin Sets Second Quarter 2011 Conference Call for Thursday, August 11, 2011 at 4:30 p.m. ET 2
(Date:8/29/2014)... review website Top10BestSEOHosting.com compares many popular hosting suppliers and ... suppliers for webmasters for webmasters who want to buy ... at affordable prices. , GoDaddy offers three Linux ... plans depends on the length of a contract. This ... flexible hosting packages, decent uptime record and beneficial support ...
(Date:8/29/2014)... Cosmetic Town has devised a system ... its doctors. Cosmetic Town utilizes a validated referral ... in their field are chosen to present their procedure. ... direct link to potentially hundreds of recommended doctors in ... to communicate through the site’s community features and multimedia ...
(Date:8/29/2014)... a famous online supplier of trendy clothes, has unveiled its ... moment, all these mini outfits are offered at discounted rates, ... is September 14. , The company’s senior spokesman states, ... hot designs, we have listed some of the best-selling items ... ladies to get high quality, fashionable clothes. Many of our ...
(Date:8/29/2014)... Panic attacks are extremely difficult to ... intense stress and fear, which appears with no particular ... insecurity and affecting relationships. , A panic attack can ... symptoms that patients can deal with. Anxiety, shortness of ... panic attacks is extremely important for sufferers, who need ...
(Date:8/29/2014)... DailyGossip.org publishes a review to the Natural Multiple ... curing multiple sclerosis in a fast and natural way. ... M. Levin, who has become well known as a ... alternative remedies for a series of health problems when ... all cases for the cure of some disorders. ...
Breaking Medicine News(10 mins):Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:60 Second Panic Solution Review Exposes Simple Panic Attacks Remedy 2Health News:New Natural Multiple Sclerosis Treatment Review Reveals Gary M. Levin’s Unique Cure 2
... undergo heart surgery are more than three times as likely ... the next three months, a new study finds. ... during the most critical post-operative recovery period," says Ellen Idler, ... study, which appears in the March issue of the ...
... The Center for Public-Private Partnerships at The Henry M. ... is pleased to announce the recipients of the 2012 ... themselves through excellence and selfless dedication to advancing medicine ... veterans and their families. The recipients will be honored ...
... are vitamin D deficient and there is an inverse ... a recent study accepted for publication in The Endocrine ... (JCEM). Recommendations for dietary vitamin D intake in ... because vitamin D deficiency is extraordinarily prevalent in this ...
... D.C. People with schizophrenia report improved functioning ... according to results announced today from a six-month ... for People with Schizophrenia , was spearheaded by ... Council) and administered at 10 community behavioral health ...
... HealthDay Reporter , MONDAY, March 5 (HealthDay News) ... College of Physicians (ACP) put the emphasis on individual risk. ... get screened starting at age 50, whereas people at high ... or family history of the disease -- should get screened ...
... (HealthDay News) -- ,Hospitalizations from angiodema, a serious swelling ... the eyes and mouth, are on the rise, new ... searched a national database for hospitalizations due to allergic ... and angiodema. While hospitalization rates for the other ...
Cached Medicine News:Health News:Marriage: A powerful heart drug in short supply 2Health News:HJF Center announces Heroes of Military Medicine award recipients 2Health News:Vitamin D deficiency linked to higher mortality in female nursing home residents 2Health News:Pilot program demonstrates measureable benefits for people with schizophrenia 2Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 2Health News:New Colon Cancer Screening Guidelines Focus on Individual Risk 3
SkinStation, powered by LHE, is Radiancys flagship product. A powerhouse by design, it incorporates todays most sought after applications all on one user-friendly system ....
Inquire...
Sebia's Hb AFSC Control provides excellent resolution of normal hemoglobins A & F and abnormal hemoglobins S & C. The control is designed for use with Sebia's Hydragel Hemoglobin and Hydragel Acid He...
... Normal and Hypergamma Controls are ... either agarose gels or Sebia's ... Our unique control manufacturing process ... the other serum components, presenting ...
Medicine Products: